Clinical Trials Browser

Not yet recruiting × Carcinoma, Renal Cell × 1 year × Clear all

NCT07602101 2026-05-22

Neoadjuvant PD-L1 Inhibitor Plus Anlotinib for Kidney Preservation in Complex Renal Cell Carcinoma

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07593040 2026-05-20

Moonlanding

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07594106 2026-05-18

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

Phase 1/2 Not yet recruiting

Carcinoma, Renal Cell

NCT07516366 2026-05-15

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Phase 1 Not yet recruiting

BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT07578025 2026-05-11

Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Phase 2 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07576725 2026-05-08

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Phase 2 Not yet recruiting

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidSarcomaThoracic

Clear-cell metastatic renal cell carcinoma, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Hodgkin Disease, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Sarcoma, Kaposi, Colorectal Neoplasms, Carcinoma, Merkel Cell

NCT07037004 2026-05-04

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07564232 2026-05-04

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

Phase 1 Not yet recruiting

Carcinoma, Renal Cell

NCT07043608 2026-05-01

ZAMBONI

Phase 2 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT07510334 2026-04-03

VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Phase 2 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07500805 2026-03-30

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

Phase 1 Not yet recruiting

Carcinoma, Renal Cell

NCT07500831 2026-03-30

Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma

Phase NA Not yet recruiting

Carcinoma, Renal Cell

NCT07494435 2026-03-27

Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07497958 2026-03-27

Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy

Phase NA Not yet recruiting

Carcinoma, Renal Cell, Acute Kidney Injury

NCT07470840 2026-03-24

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07480044 2026-03-18

A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery

Phase NA Not yet recruiting

Emergence Delirium, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT07465458 2026-03-16

RASROP-003

Not yet recruiting

Carcinoma, Renal Cell

NCT07077083 2026-03-11

CAIX PET/CT

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07460206 2026-03-10

PRELUDE

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT06959433 2026-02-27

Lu-177 PSMA Treatment in Cell Renal Carcinoma

Phase 3 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07243067 2026-02-27

Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer

Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Phase 3 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07351266 2026-01-20

Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors

Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07346404 2026-01-16

RUBIKID

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Neovascularization, Pathologic

NCT06770855 2026-01-09

Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)

Phase NA Not yet recruiting

Carcinoma, Renal Cell

NCT07321197 2026-01-06

RECLND

Phase NA Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07277972 2025-12-11

Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07233668 2025-12-03

IVE in mRCC

Phase NA Not yet recruiting

Carcinoma, Renal Cell

NCT07256223 2025-12-01

A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07252661 2025-11-28

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

Phase 1 Not yet recruiting

DermatologicEndocrineGastrointestinalGenitourinaryHead & Neck

Thyroid cancer, medullary, Carcinoma, Renal Cell, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis

NCT07246759 2025-11-24

NEUTROFLOW

Not yet recruiting

BreastDermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT07226544 2025-11-10

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT07218692 2025-10-20

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Phase 2 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT07187869 2025-09-23

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

Phase 1 Not yet recruiting

Carcinoma, Renal Cell

NCT07165418 2025-09-10

A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI

Phase 3 Not yet recruiting

Carcinoma, Renal Cell

NCT07087158 2025-07-28

A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma

Phase 2 Not yet recruiting

Carcinoma, Renal Cell